Vanda Pharmaceuticals Inc. (10)
Browse by Contract Category
Contracts
-
License Agreement, dated January 13, 2022, by and among MSN Pharmaceuticals Inc., MSN Laboratories Private Limited, Impax Laboratories LLC and the registrant
(Filed With SEC on May 6, 2022)
-
Description of Securities of the registrant
(Filed With SEC on February 24, 2022)
-
Fifth Amendment to Lease Agreement, dated April 11, 2019
(Filed With SEC on February 11, 2021)
-
Amended and Restated Employment Agreement, dated July 27, 2020, by and between Kevin Moran and the registrant
(Filed With SEC on July 29, 2020)
-
Manufacturing Agreement, dated January 24, 2014, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to HETLIOZ
(Filed With SEC on February 24, 2022)
-
Manufacturing Agreement, dated May 6, 2016, by and between Patheon Pharmaceuticals Inc. and the registrant (relating to Fanapt
(Filed With SEC on February 24, 2022)
-
Sixth Amendment to Lease Agreement, dated May 7, 2020, by and between Square 54 Office Owner LLC and the registrant
(Filed With SEC on February 11, 2021)
-
Amended and Restated Employment Agreement, dated May 5, 2020, by and between Kevin Moran and the registrant
(Filed With SEC on May 7, 2020)
-
Employment Agreement, dated July 3, 2019, by and between Aranthan "AJ" Jones II and the registrant
(Filed With SEC on November 7, 2019)
-
Employment Agreement, dated August 5, 2019, by and between Joakim Wijkstrom and the registrant
(Filed With SEC on November 7, 2019)